Interestingly, blocking the Smad signaling pathway, by means of Smad3/4 CRISPR KO, significantly increased both tumor volume (Figure 4b) and tumor mass (Figure 4c) compared to the non-targeting control (scrambled) and parental cell (A375m) groups. The gene discussed is SMAD3; the disease is neoplasm.